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New randomised trials should be planned and reported
taking account of knowledge from a systematic review
of the existing research, but there is little empirical evi-
dence to show how systematic reviews are used in the
planning stages of new trials.
A systematic review could be used to inform the
design of a new trial in several ways: (1) to choose the
most appropriate forms of the interventions for the
experimental and control groups, (2) to inform the sam-
ple size calculation (e.g. an estimate of the standard
deviation), (3) to aid the choice decision of outcomes to
measure (or the definition of an outcome), (4) to iden-
tify potential problems with consent, treatment withdra-
wal or retention, (5) to predict likely adverse events that
may not otherwise be expected.
Furthermore, a systematic review could be used to
conduct a sample size calculation for an updated meta-
analysis incorporating the existing evidence and the
eventual findings of the trial being planned. Although
there is debate as to whether a trial should be powered
in its own right or as part of an updated meta-analysis,
there might be outcomes that will only have adequate
power in the context of a meta-analysis. Among the
issues to consider are whether the trial is justified if the
existing meta-analysis is significant, whether it is possi-
ble to conduct a trial involving fewer patients and thus
reach a decision on the most appropriate treatment ear-
lier, and whether statistical heterogeneity might require
the trial to be larger than the estimate if it was powered
in isolation.
We present a sources of data on the use of systematic
reviews in the design and conduct of randomised trials:
a cohort of HTA-funded studies in which we explore
how the trial design was informed by the existing evi-
dence base.
Our findings will provide important information for
trialists and trial funders.
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